NCT02429869View on ClinicalTrials.gov

Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant

PHASE4CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

February 24, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

HIVKidney TransplantLiver Transplant

Interventions

DRUG

everolimus

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

amfAR, The Foundation for AIDS Research

OTHER

collaborator

Novartis

INDUSTRY

lead

University of California, San Francisco

OTHER